Breaking Driver Rams Car Into Pedestrians in Caen, France; One Dead, Ten Injured Mbappé’s Hat-Trick Fuels Real Madrid Victory, Sávio Scores on Tottenham Debut Asian Stocks Mixed Amid Economic Updates and Wall Street Losses Investigators Probe Fatal Nursery Fire at Islamabad Hospital Former Malaysian PM Ismail Sabri Yaakob Charged With Asset Declaration Failure

Thursday August 27, 2026

Reporter

Vector Sciences & Therapeutics

7Articles Published

5Communities Covered

Published Articles

Press Release

Vector Science and Therapeutics Corp. Enters Into an Investor Relations Agreement and Grants Options

Aug 25

Press Release

Vector Science & Therapeutics (TSXV: PAIN) Begins Peptide Production as First Suite at LyoGenesis Manufacturing Comes Online

Aug 24

Press Release

Vector Science and Therapeutics Corp. (TSXV: PAIN) Files Provisional Patent Application on Integrated Platform for Orthopedic Tissue Regeneration Using Peptides

Aug 20

Press Release

/C O R R E C T I O N — Vector Sciences & Therapeutics/

Aug 19

Press Release

Verlytix Launches as a Related Company to LyoGenesis Manufacturing

Aug 18

Press Release

Vector Science and Therapeutics Corp. Signs Amended, 10-Year Manufacturing and Testing Agreement with LyoGenesis Holdings

Aug 17

Press Release

Vector Science & Therapeutics Corp., LyoGenesis Plus and Wynn Pharmaceuticals Announce Strategic Collaboration to Develop and Manufacture Critical Care Medical Products

Jul 28